[Alteration of the guidelines on pharmaceuticals of the National Committee of Physicians and Health Insurers with regard to atypical neuroleptics. Statement of the German Scoiety of Psychiatry, Psychotherapy and Neurology (DGPPN)].
Fritze
J
J
Schmauss
M
M
D000208:Acute Disease; D014150:Antipsychotic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D005858:Germany; D006291:Health Policy / Q000331:legislation & jurisprudence*; D006801:Humans; D009313:National Health Programs / Q000331:legislation & jurisprudence*; D017410:Practice Guidelines as Topic; D012559:Schizophrenia / Q000188:drug therapy*
D014150:Antipsychotic Agents